David McCartney is an Ophthalmology physician. OpenAlex indexes 35 publications with 830 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 4th St
2a100
Lubbock, TX 794300002
Telephone
806-743-2020Registry record last updated 11 Jul 2007.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20251 payment
- BIOTISSUE HOLDINGS, INC.Program year20232 payments
- Alcon Vision LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
70%Corticosteroid25.4%Prednisolone Acetate100%Part D≥224 patientsProstaglandin Analog19.3%Latanoprost81%Lumigan14%Travoprost6%Part D<11 patients+ 6 more classes in this area
Anti-infectives
20.4%Fluoroquinolone Antibacterial10.7%Moxifloxacin100%Part D≥98 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.6%Valacyclovir100%Part D≥26 patients+ 3 more classes in this area
Cardiovascular
6.4%Beta blocker6.4%Timolol Maleate100%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1989–1990 per NIH RePORTER. The latest:
- REDUCTION OF ASTIGMATISM: BIOMECHANICAL FACTORS
Texas Tech University Health Scis Center
FY1990S07RR005773 - REDUCTION OF ASTIGMATISM: BIOMECHANICAL FACTORS
Texas Tech University Health Scis Center
FY1989S07RR005773
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”